Why did I participate in an HIV vaccine study? Experiences of participation in the first phase II HIV vaccine trial in Mozambique: An ancillary study using a mixed-method approach.

Autor: Ubisse Capitine IP; Instituto Nacional de Saúde (INS), Maputo Province, Mozambique.; Centre for International Health (CIH), LMU Munich, Munich, Germany., Manhiça ÁM; Instituto Nacional de Saúde (INS), Maputo Province, Mozambique., Tembe Júnior P; Instituto Nacional de Saúde (INS), Maputo Province, Mozambique., Ramgi PM; Instituto Nacional de Saúde (INS), Maputo Province, Mozambique., Chicumbe S; Instituto Nacional de Saúde (INS), Maputo Province, Mozambique., Kroidl A; Centre for International Health (CIH), LMU Munich, Munich, Germany.; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.; German Center for Infection Research (DZIF), Munich, Germany., Fischer MR; Centre for International Health (CIH), LMU Munich, Munich, Germany.; Institute of Medical Education, LMU University Hospital, LMU Munich, Munich, Germany., De Schacht C; Friends in Global Health, Maputo, Mozambique.

Publikováno v: Vaccine: X [Vaccine X] 2024 Jun 06; Vol. 19, pp. 100510. Date of Electronic Publication: 2024 Jun 06 (Print Publication: 2024).